Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma

NCT01613313 is registered in ClinicalTrials.gov with Zachary Gerut as lead sponsor.

NCT NCT01613313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01613313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma
Lead sponsor
Zachary Gerut
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2012
Completion date
October 31, 2013
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lipoma